Search companies or stocks...
RGENRepligen Corporation
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia…
Current stock price of Repligen Corporation (RGEN) stock is $172.94. The stock price is +1.72% higher in the session. The intraday range can be seen from this page. Volume of Repligen Corporation (RGEN) stock is 959.27K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Repligen Corporation (RGEN) can change with earnings, company news, and overall market sentiment. Repligen Corporation operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Repligen Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RGEN on this page is 96.08. EPS on this page is 1.80. Compare those figures with peers and growth expectations before deciding if the current Repligen Corporation price is justified.
Historical performance for Repligen Corporation (RGEN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RGEN reacted to past earnings and market events.
Buying Repligen Corporation (RGEN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
